MAPK14 (T106M) NanoBRET Kinase Assay

MAPK14 (T106M) NanoBRET Target Engagement Intracellular Kinase Assay for screening of compounds binding to the target.

Target Overview

Target

MAPK14 (T106M)

HGNC Symbol

MAPK14 (T106M)

Synonyms

p38-alpha, CSBP, CSBP1, p38alpha, p38a

Cell Line

HEK293 human epithelial cell line from ATCC

Assay Properties

Assay Format

384-well plate format using Promega’s NanoBRET TE Intracellular Kinase Assay

Assay Protocol

HEK293 cells transiently expressing NanoLuc-MAPK14 (T106M) Fusion Vector were seeded into the wells of 384-well plates. The cells were pre-treated with the NanoBRET Tracer K-10 and then treated with reference compound CC1-Pan Kinase Inhibitor for 1 hour. The BRET signal was measured on an Envision 2104 Multilabel Reader. IC50 value was calculated and IC50 curve was plotted using the GraphPad Prism program based on a sigmoidal dose response equation.

Readout

Binding of compound to target kinase

Reference Compound IC50s

Compounds	IC50 (M)
CC1-Pan kinase Inhibitor	1.58E-08

Screening Location

Malvern, PA, USA

Reference Compound IC50 for MAPK14 (T106M)

Reference compound IC50 for MAPK14 (T106M)

PDF